These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 29765539)
1. CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity. Saulino DM; Younes PS; Bailey JM; Younes M Oncotarget; 2018 Apr; 9(30):21289-21295. PubMed ID: 29765539 [TBL] [Abstract][Full Text] [Related]
2. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer. Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389 [TBL] [Abstract][Full Text] [Related]
3. Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma. Younes M; Ly CJ; Singh K; Ertan A; Younes PS; Bailey JM Oncotarget; 2018 Dec; 9(102):37715-37720. PubMed ID: 30701026 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CRM1 in pancreas cancer. Huang WY; Yue L; Qiu WS; Wang LW; Zhou XH; Sun YJ Clin Invest Med; 2009 Dec; 32(6):E315. PubMed ID: 20003838 [TBL] [Abstract][Full Text] [Related]
5. The combination of strong immunohistochemical mtTFA expression and a high survivin index predicts a shorter disease-specific survival in pancreatic ductal adenocarcinoma. Kimura T; Kitada S; Uramoto H; Zhi L; Kawatsu Y; Takeda T; Horie S; Nabeshima A; Noguchi H; Sasaguri Y; Izumi H; Kohno K; Yamada S Histol Histopathol; 2015 Feb; 30(2):193-204. PubMed ID: 25108120 [TBL] [Abstract][Full Text] [Related]
6. Discovery of Aminoratjadone Derivatives as Potent Noncovalent CRM1 Inhibitors. Jian L; Zscherp R; Beutling U; Shen X; Xu S; Zhang X; Brönstrup M; Klahn P; Sun Q J Med Chem; 2023 Sep; 66(17):11940-11950. PubMed ID: 37595020 [TBL] [Abstract][Full Text] [Related]
7. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Rodríguez JA; Span SW; Ferreira CG; Kruyt FA; Giaccone G Exp Cell Res; 2002 Apr; 275(1):44-53. PubMed ID: 11925104 [TBL] [Abstract][Full Text] [Related]
8. Heterozygous mutation of cysteine528 in XPO1 is sufficient for resistance to selective inhibitors of nuclear export. Neggers JE; Vanstreels E; Baloglu E; Shacham S; Landesman Y; Daelemans D Oncotarget; 2016 Oct; 7(42):68842-68850. PubMed ID: 27634897 [TBL] [Abstract][Full Text] [Related]
9. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models. Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588 [TBL] [Abstract][Full Text] [Related]
10. The expression of CRM1 is associated with prognosis in human osteosarcoma. Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467 [TBL] [Abstract][Full Text] [Related]
11. Survivin expression and serum levels in pancreatic cancer. Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480 [TBL] [Abstract][Full Text] [Related]
12. DNA-Methylation-Caused Downregulation of Azmi AS; Li Y; Aboukameel A; Muqbil I; Philip PA; Mohammad RM Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31382411 [TBL] [Abstract][Full Text] [Related]
14. CRM1 and chromosomal passenger complex component survivin are essential to normal mitosis progress and to preserve keratinocytes from mitotic abnormalities. Labarrade F; Botto JM; Domloge N Int J Cosmet Sci; 2016 Oct; 38(5):452-61. PubMed ID: 26859314 [TBL] [Abstract][Full Text] [Related]
15. [Expression of nuclear export factor CRM1 and p27 in glioma]. Wang DL; Wang YC; Lu P; E Q; Shi GS Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):454-7. PubMed ID: 19035116 [TBL] [Abstract][Full Text] [Related]
16. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N Urol J; 2009; 6(2):101-8. PubMed ID: 19472128 [TBL] [Abstract][Full Text] [Related]
17. The past, present, and future of CRM1/XPO1 inhibitors. Wang AY; Liu H Stem Cell Investig; 2019; 6():6. PubMed ID: 30976603 [TBL] [Abstract][Full Text] [Related]
18. Nuclear Export Inhibition for Pancreatic Cancer Therapy. Muqbil I; Azmi AS; Mohammad RM Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29735942 [TBL] [Abstract][Full Text] [Related]
19. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis. Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837 [TBL] [Abstract][Full Text] [Related]